Company intelligence / Profile preview

GHK Pharmaceuticals

Bellevue, Washington, USA

Ownership: Private
Development stage: Other

Overview

GHK Pharmaceuticals is a biotechnology company dedicated to the research and development of the GHK-Cu peptide, a naturally occurring copper complex discovered by the company's founder, Dr. Loren Pickart. The company focuses on the peptide's regenerative properties, specifically its ability to modulate gene expression, promote collagen synthesis, and accelerate wound healing. GHK Pharmaceuticals leverages this technology for applications in anti-aging skincare, hair regrowth, and the treatment of inflammatory conditions. Beyond dermatology, the company investigates the systemic benefits of GHK-Cu in areas such as pulmonary health and tissue repair.

Therapeutic areas: DermatologyPulmonology
Modalities: PeptidesBiologic
Industry: Biotech

Beyond the preview

Go deeper on GHK Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GHK Pharmaceuticals.

Explore the full profile